Source: Health Products Regulatory Authority (ZA) Publisher: Zydus Healthcare SA (Pty) Ltd, Southdowns Office Park, Building B, Ground Floor, 22 Karee Street, Centurion, Pretoria 0157
ZEDRAST 0,5 mg soft capsules.
| Pharmaceutical Form |
|---|
|
Capsules, soft. Opaque, yellow, oblong shaped soft gelatine capsules containing a clear, colourless to slightly yellowish oily liquid. |
Each capsule contains 0,5 mg dutasteride.
Preservatives: 0,2% m/m methyl hydroxybenzoate and 0,03% m/m propyl hydroxybenzoate.
Sugar free.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Dutasteride reduces circulating levels of dihydrotestosterone (DHT) by inhibiting both type 1 and type 2, 5α-reductase isoenzymes which are responsible for the conversion of testosterone to DHT. |
| List of Excipients |
|---|
|
Capsule contents: Butylated hydroxytoluene Capsule shell: Ferric oxide yellow (colourant) |
Aluminium-aluminium blister strips containing 6 soft gelatine capsules, packed in an outer container.
Pack size: 6
OR
Opaque PVC/PVDC and aluminium blister strips containing 10 soft gelatine capsules, packed in an outer container.
Pack size: 10
Zydus Healthcare SA (Pty) Ltd, Southdowns Office Park, Building B, Ground Floor, 22 Karee Street, Centurion, Pretoria 0157
54/21.12/0491
| Drug | Countries | |
|---|---|---|
| ZEDRAST | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.